Pfizer's innovative business should grow faster after it divests its off-patent division Upjohn in 2020 to create Viatris and ...

Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global presence. GCCPL provides customized, technology-driven healthcare solutions to meet the evolving needs of today’s market ...

President Donald Trump’s pick to be U.S. surgeon general has said the nation’s medical and food systems are corrupted by ...

AnaptysBio, Inc.'s rosnilimab shows promise in RA & ulcerative colitis, targeting $20B+ markets. Phase 2b results highlight ...